| Cooperative Group/Study |
Integral/Integrated |
Cancer Site |
Assay/Test/Assessment |
| SWOG 1201 |
Integral Biomarker |
Gastric/GE Junction |
ERCC-1 |
| ACOSOG Z11103 |
Integral Biomarker |
Breast |
Ki67 |
| CALGB 80803 |
Integral Biomarker & Imaging |
Esophageal |
central pathology & PET scan |
| RTOG 1016 |
Integral Biomarker |
Oropharynx |
p16 |
| COG ACCL 0933 |
Integrated Biomarkers |
Peds ACL |
galactomannan & β-D-glucan |
| COG ACCL 0934 |
Integrated Biomarkers |
Peds ACL |
bacterial isolates from stool/perirectal swabs |
| COG AALL 1131 |
Integrated Imaging |
Peds ALL |
MRI |
| SWOG 0819 |
Integral & Integrated Biomarkers |
NSCLC |
KRAS, EGFR |
| SWOG S1007 |
Integral Biomarker |
Breast |
OncoType DX |
| COG AALL 0932 |
Integrated QOL |
Peds ALL |
neuropathy |
| COG AAML 1031 |
Integral & Integrated Biomarkers |
Peds AML |
FLT3/ITD, KIT, MRD, WT1, RUNX1, TET2, MLL-PTD, c-CBL, CEBPa, CD74, PSMB5 |
| RTOG 0825/ACRIN 6686 |
Integrated Imaging |
Glioblastoma |
MRI |
| RTOG 1010 |
Integral Biomarker |
Esophageal |
HER2 |
| NCCTG N0577 |
Integral Biomarker |
Glioma |
translocation of 1p:19q |
| CALGB 30801 |
Integral & Integrated Biomarkers |
Lung |
COX-2, urinary PGE-M |
| COG AAML 0531 |
Integral Biomarker |
Peds AML |
FLT3/ITD, MRD, CEBPα |
| NSABP MA 32-F |
Integrated QOL |
Breast |
Fatigue, Behavioral & Health Outcomes |
| GOG UC 0604 |
Integrated QOL |
Uterine |
PROMIS 7 (HRQOL) |
